Endometrial Staining of CD56 (Uterine Natural Killer), BCL-6, and CD138 (Plasma Cells) Improve Diagnosis and Clinical Pregnancy Outcomes in Unexplained Infertility and Recurrent IVF Failures: Standardization of Diagnosis with Digital Pathology
Diagnostics · 26.04.2023 · 13 (9) · 1557
DOI: 10.3390/diagnostics13091557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 26.04.2023. Verfasst von Suheyla Ekemen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vocational School of Health Services, Kerem Aydınlar Campus, Acıbadem University, Istanbul 34752, Turkey. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In women with unexplained infertility (UI) and recurrent in vitro fertilization (IVF) failures, the etiology is often unclear. Endometrial immune perturbations and the use of immune markers associated with these dysregulations are of great interest in the diagnosis and treatment of UI. However, reliable biomarkers and standardized quantification methods are lacking. Here, to address endometrial immune dysregulation in UI patients with recurrent IVF failures, we performed endometrial tissue sampling and immunostaining of CD56 (uNK), CD138, and BCL-6. Of these cases, 57.9% had positive CD56 in the endometrial stroma, while 46.1% had positive BCL-6 in the glandular epithelium, and 14.5% of the cases were found to be positive for CD138. Combined staining rates were 60.5%, 68.4%, and 71.05% for (CD56 or BCL-6), (CD56 or CD138), and (CD56, BCL-6, or CD138), respectively. There was a significant correlation between CD56 and BCL-6 positivity, while CD138 positivity was an independent parameter. After the recommended targeted therapy, pregnancy rates were found to increase from 58.5% to 61.6% and 73.8% in CD56-positive, (CD56- or BCL-6-positive), and (CD56-, BCL-6-, or CD138-positive) cases, respectively. Notably, a retrospective evaluation of digital pathology and light microscopy results showed a significant correlation. This study suggests that the examination of CD56, BCL-6, and CD138 in the same endometrial sample may be an effective method in determining the etiology of UI and reaching an early diagnosis and treatment options. Moreover, digital pathology can be used in the evaluation of CD56 and BCL-6 to provide objective, rapid, and reliable results.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vocational School of Health Services, Kerem Aydınlar Campus, Acıbadem University, Istanbul 34752, Turkey.
- Acibadem Central Pathology Laboratory, Kerem Aydinlar Campus, Istanbul 34752, Turkey.
- Department of Pathology, Dr. Cemil Tascioglu City Hospital, University of Health Sciences, Istanbul 34668, Turkey.
- School of Medicine, Bahcesehir University, Istanbul 34349, Turkey.
- Women's Health and Gynecological Nursing, Institute of Health Sciences, Biruni University, Istanbul 34010, Turkey.
- Department of Public Health, School of Medicine, Istanbul Okan University, Istanbul 34947, Turkey.
ORCID-Profile: Suheyla Ekemen, Cem Comunoglu, Ebru Bilir, Nilay Etiler, Cevayir Coban
Zitieren
APA
Ekemen, S., Comunoglu, C., Kayhan, C. K., Bilir, E., Cavusoglu, I., Etiler, N., Bilgi, S., Ince, U., Coban, C., & Erden, H. F. (2023). Endometrial Staining of CD56 (Uterine Natural Killer), BCL-6, and CD138 (Plasma Cells) Improve Diagnosis and Clinical Pregnancy Outcomes in Unexplained Infertility and Recurrent IVF Failures: Standardization of Diagnosis with Digital Pathology. Diagnostics, 13(9), 1557. https://doi.org/10.3390/diagnostics13091557
Vancouver
Ekemen S, Comunoglu C, Kayhan CK, Bilir E, Cavusoglu I, Etiler N, et al. Endometrial Staining of CD56 (Uterine Natural Killer), BCL-6, and CD138 (Plasma Cells) Improve Diagnosis and Clinical Pregnancy Outcomes in Unexplained Infertility and Recurrent IVF Failures: Standardization of Diagnosis with Digital Pathology. Diagnostics. 2023;13(9):1557. doi:10.3390/diagnostics13091557
BibTeX
@article{Ekemen2023,
author = {Ekemen, Suheyla and Comunoglu, Cem and Kayhan, Cavit Kerem and Bilir, Ebru and Cavusoglu, Ilkay and Etiler, Nilay and Bilgi, Selcuk and Ince, Umit and Coban, Cevayir and Erden, Halit Firat},
title = {Endometrial Staining of CD56 (Uterine Natural Killer), BCL-6, and CD138 (Plasma Cells) Improve Diagnosis and Clinical Pregnancy Outcomes in Unexplained Infertility and Recurrent IVF Failures: Standardization of Diagnosis with Digital Pathology},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {9},
pages = {1557},
doi = {10.3390/diagnostics13091557}
}
EUVIMED